About Jonathan Reis
Form D filings for Atacama Therapeutics in 2024 list Jonathan Reis as director.
Jonathan Reis first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Jonathan Reis in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jonathan Reis works with at each company, as listed on that company's latest Form D.
Atacama Therapeutics, Inc. · Form D/A, May 7, 2024
JB
Joseph Baron
Chief Executive Officer and director